Elevated PI3K/AKT signaling has been identified in both HHT patient skin biopsies and mutant ECs in HHT mouse models, and inhibiting this pathway successfully rescues AVMs in mice [9, 10]. The gene discussed is AKT1; the disease is hereditary hemorrhagic telangiectasia.